『Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers A Phase 1/2 Single-Group Open-Label Trial』（JAMA Oncol. doi:10.1001/jamaoncol.2020.1260 Published online May 28, 20…